Literature DB >> 26391389

Causes of death in French cystic fibrosis patients: The need for improvement in transplantation referral strategies!

Clémence Martin1, Cécile Hamard2, Reem Kanaan3, Véronique Boussaud4, Dominique Grenet5, Michel Abély6, Dominique Hubert7, Anne Munck8, Lydie Lemonnier9, Pierre-Régis Burgel10.   

Abstract

BACKGROUND: Little data exist on causes of death in cystic fibrosis (CF) patients in the era of lung transplantation.
METHODS: Deaths in CF patients in France (2007-2010) were identified using the French CF Registry and causes of deaths were determined based on medical files by a mortality adjudication committee.
RESULTS: Of 256 deaths, half occurred after lung transplantation and were related to early or late complications of transplantation, whereas half occurred in patients who did not receive lung transplantation and were primarily related to respiratory failure or massive hemoptysis. Among patients who did not receive lung transplantation, only 19% died while waiting on a lung transplantation list. Lack of listing for lung transplantation was primarily related to late, or to lack of transplantation referral, rather than to contraindication to transplantation.
CONCLUSIONS: These data suggest that improvement in transplantation referral strategies may result in transplantation-related survival benefits.
Copyright © 2015 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cystic fibrosis exacerbation; Hemoptysis; Lung transplantation; Respiratory failure

Mesh:

Year:  2015        PMID: 26391389     DOI: 10.1016/j.jcf.2015.09.002

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  19 in total

Review 1.  Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelines.

Authors:  Kathleen J Ramos; Patrick J Smith; Edward F McKone; Joseph M Pilewski; Amy Lucy; Sarah E Hempstead; Erin Tallarico; Albert Faro; Daniel B Rosenbluth; Alice L Gray; Jordan M Dunitz
Journal:  J Cyst Fibros       Date:  2019-03-27       Impact factor: 5.482

2.  Addressing lung transplant with adults with cystic fibrosis: A qualitative analysis of patients' perspectives and experiences.

Authors:  Kathleen J Ramos; Mara R Hobler; Ruth A Engelberg; J Randall Curtis; Miriam I Zander; Shacole S Howard; Christopher H Goss; Moira L Aitken
Journal:  J Cyst Fibros       Date:  2019-04-17       Impact factor: 5.482

3.  Resistance evolution can disrupt antibiotic exposure protection through competitive exclusion of the protective species.

Authors:  Angus M Quinn; Michael J Bottery; Harry Thompson; Ville-Petri Friman
Journal:  ISME J       Date:  2022-07-20       Impact factor: 11.217

4.  Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation.

Authors:  Lorriana E Leard; Are M Holm; Maryam Valapour; Allan R Glanville; Sandeep Attawar; Meghan Aversa; Silvia V Campos; Lillian M Christon; Marcelo Cypel; Göran Dellgren; Matthew G Hartwig; Siddhartha G Kapnadak; Nicholas A Kolaitis; Robert M Kotloff; Caroline M Patterson; Oksana A Shlobin; Patrick J Smith; Amparo Solé; Melinda Solomon; David Weill; Marlies S Wijsenbeek; Brigitte W M Willemse; Selim M Arcasoy; Kathleen J Ramos
Journal:  J Heart Lung Transplant       Date:  2021-07-24       Impact factor: 13.569

5.  Colonization of CF patients' upper airways with S. aureus contributes more decisively to upper airway inflammation than P. aeruginosa.

Authors:  Wibke Katharina Janhsen; Christin Arnold; Julia Hentschel; Thomas Lehmann; Wolfgang Pfister; Michael Baier; Klas Böer; Kerstin Hünniger; Oliver Kurzai; Uta-Christina Hipler; Jochen Georg Mainz
Journal:  Med Microbiol Immunol       Date:  2016-07-04       Impact factor: 3.402

Review 6.  The future of cystic fibrosis care: a global perspective.

Authors:  Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen
Journal:  Lancet Respir Med       Date:  2019-09-27       Impact factor: 30.700

7.  Cystic fibrosis physicians' perspectives on the timing of referral for lung transplant evaluation: a survey of physicians in the United States.

Authors:  Kathleen J Ramos; Ranjani Somayaji; Erika D Lease; Christopher H Goss; Moira L Aitken
Journal:  BMC Pulm Med       Date:  2017-01-19       Impact factor: 3.317

Review 8.  Harnessing Neutrophil Survival Mechanisms during Chronic Infection by Pseudomonas aeruginosa: Novel Therapeutic Targets to Dampen Inflammation in Cystic Fibrosis.

Authors:  Benoît S Marteyn; Pierre-Régis Burgel; Laurent Meijer; Véronique Witko-Sarsat
Journal:  Front Cell Infect Microbiol       Date:  2017-06-30       Impact factor: 5.293

9.  An empirical method to cluster objective nebulizer adherence data among adults with cystic fibrosis.

Authors:  Zhe H Hoo; Michael J Campbell; Rachael Curley; Martin J Wildman
Journal:  Patient Prefer Adherence       Date:  2017-03-24       Impact factor: 2.711

10.  TALEN-Mediated Gene Targeting for Cystic Fibrosis-Gene Therapy.

Authors:  Emily Xia; Yiqian Zhang; Huibi Cao; Jun Li; Rongqi Duan; Jim Hu
Journal:  Genes (Basel)       Date:  2019-01-11       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.